C. Schwarz et al., BETA-THALASSEMIA IN GERMANY - MOLECULAR-G ENETICS AND CLINICAL PHENOTYPE IN THE IMMIGRANT AND IN THE NON-IMMIGRANT POPULATIONS, Klinische Padiatrie, 209(4), 1997, pp. 172-177
Background In Germany there are about 300-400 patients with homozygous
beta-thalassaemia who immigrated from endemic regions mostly in the M
editerranean. In the non-immigrant population beta-thalassaemia is rar
e with only single case reports of homozygous patients. Heterozygous b
eta-thalassaemia, however, is more common and must be considered in th
e differential diagnosis of hypochromic anemia. Patients and Methods H
ere, clinical and molecular data of 221 homozygous patients from immig
rant families and 256 non-immigrant German heterozygous individuals ar
e presented. Results Clinically, 87% (n=192) of the homozygotes are re
gularly transfused and classified as thalassaemia major (TM). The othe
r 13% (n=29) are not (regularly) transfused and thus classified as tha
lassaemia intermedia (TI). There is a wide spectrum 39 beta-globin gen
e mutations and even the most common three, IVSI-110 G-A, NS 39, and I
VSI-6 T-C occur with relatively low frequencies of 28%, 22%, and 9%, r
espectively. In 17/29 (58%) TI patients,, mild'' mutations are found t
hat inactivate the affected gene incompletely. In 16/29 (55%) there ar
e mutations that are associated with increased gamma-globin gene activ
ity. alpha-Thalassaemia is rare and only found in 3/29 TI-patients. In
the 256 Germans with heterozygous beta-thalassaemia there are 27 diff
erent beta-globin gene mutations. The 3 most common are Mediterranean
mutations together accounting for 61%. Also relatively common (5%; n=1
3) is an otherwise rare frameshift mutation of codon 83 (FS83 Delta G)
. The other mutations occur in <10 individuals only. Two mutations des
cribed here are novel. One of them affects position-2 of the intron 1
splice acceptor site (IVSI-129 A-G) and the other is a deletion of a s
ingle G in codon 15/16 (FS 15/16 Delta G). Conclusions Taken together,
a plausible molecular pathogenesis for the observed phenotype (TM vs.
TI) can be identified in most homozygous patients thus allowing for r
ational counselling of the affected families. In heterozygous Germans
beta-thalassaemia has probably been imported from the Mediterranean in
about 2/3 of the cases whereas in the remaining 1/3 it has probably o
riginated locally.